278 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Hikma Acquisitions

Hikma has acquired 9 companies and its latest acquisition was Xellia Pharmaceutical's United States Finished Dosage Form Business and Assets on Jun 2024

Unlock 6 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Xellia Pharmaceutical's United States Finished Dosage Form Business and Assets

Jun 2024

Source »
$135M
-

-

Teligent Inc Company's Canadian Assets

Jan 2022

Source »
$45.8M
-
Custopharm, Inc.

Sep 2021

Source »
$425M
Custopharm is a California-based medical device company that develops and commercializes complex sterile injectable products for the pharmaceutical industry.

-

Medlac Pharma Italy Co

Nov 2018

Source »
undisclosed
-
EIMC United Pharmaceuticals

Sep 2015

Source »
undisclosed
EIMC United Pharmaceuticals is a manufacturer and distributor of oncology and intensive care products.

Frequently Asked Questions about Hikma

  1. What companies did Hikma acquire?

    Companies acquired by Hikma include , and Custopharm

  2. How many acquisitions does Hikma have?

    Hikma has acquired 9 companies including , and Custopharm.

  1. How many acquisitions did Hikma make in 2024?

    In 2024 Hikma acquired 1 companies including undefined.